Filing Flows

Filing Flows › Volitionrx (VNRX) › Next earnings date

Volitionrx (VNRX) earnings on Nov 12, 2026: what to expect

Volitionrx (VNRX) is expected to report earnings on Nov 12, 2026 (estimated), in 4 days, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$0.31 (1 estimate) on revenue of $696K, against −$1.06 and $627K a year ago. It beat the EPS estimate in 25% of the quarters on record; Filing Flows' model gives it a 59% chance of beating next time.

Report dateNov 12, 2026 (estimated)
Days to go4
EPS estimate−$0.31
Revenue estimate$696K
Beat rate25%

What to watch

Last quarter (Q2 2026) the lines that make up revenue grew like this; the report shows whether the trend holds:

Volitionrx: revenue lines, growth year over year, Q2 2026Volitionrx: revenue lines, growth year over year, Q2 2026Revenue-2%

Filing Flows' own estimate from the SEC figures — the same quarter last year times recent growth — is EPS −$1.06 on revenue of $1.6M, against the analysts' −$0.31.

The last report

Volitionrx reported revenue of $399K for the second quarter 2026 (-2% Y/Y), net loss $7.3M. How it makes money → · Every quarter →

Volitionrx: EPS against the estimate, last 4 reportsVolitionrx: EPS against the estimate, last 4 reportsEstimateReported−$1.04−$1.06Nov 25−$0.80−$0.91Mar 26−$0.73−$0.84May 26−$0.67−$0.59Aug 26
Latest (Aug 26): Estimate −$0.67, Reported −$0.59.

Volitionrx's latest quarter

Volitionrx, Q2 2026: revenue $399K (-2% year over year), net loss $7.3M, operating cash flow −$5.2M. The chart follows the revenue to costs, profit and cash.

Questions

When does VNRX report earnings?

Volitionrx is expected to report on Nov 12, 2026 (estimated).

What are analysts expecting from Volitionrx?

EPS of −$0.31 and revenue of $696K for the quarter.

Does Volitionrx usually beat earnings?

It beat the consensus EPS estimate in 25% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.